Company
Every investor coverage indicates participated in a round Dana-Farber Cancer Institute raised.
Companies Dana-Farber Cancer Institute acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Sara Buhrlage | Associate Professor | Brandon Capital portfolio |
| Jarrod Marto | Associate Professor | Brandon Capital portfolio |
Stories naming Dana-Farber Cancer Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.